Sign In
Buy EG
$318.12
-2.67 (-0.83%)
At Close: Jun 03, 2026
Everest Group Q1 Earnings Miss on Higher Catastrophe Losses
04:15pm, Thursday, 01'st May 2025
EG's Q1 results reflect catastrophe losses, stemming primarily from the California wildfires.
Everest Group, Ltd. (EG) Q1 2025 Earnings Call Transcript
02:03pm, Thursday, 01'st May 2025
Everest Group, Ltd. (NYSE:EG ) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Company Participants Matthew Rohrmann - Head of Investor Relations Jim Williamson - President and Chief Executive
Compared to Estimates, Everest Group (EG) Q1 Earnings: A Look at Key Metrics
08:35pm, Wednesday, 30'th Apr 2025
Although the revenue and EPS for Everest Group (EG) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Str
Everest Group (EG) Q1 Earnings and Revenues Miss Estimates
06:45pm, Wednesday, 30'th Apr 2025
Everest Group (EG) came out with quarterly earnings of $6.45 per share, missing the Zacks Consensus Estimate of $7.46 per share. This compares to earnings of $16.32 per share a year ago.
Everest Reports First Quarter 2025 Results
04:15pm, Wednesday, 30'th Apr 2025
HAMILTON, Bermuda--(BUSINESS WIRE)--Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing best-in-class property, casualty, and specialty reinsurance and insurance solutions, today re
Will Catastrophe Loss Weigh on Everest Group's Q1 Earnings?
09:40am, Friday, 25'th Apr 2025
EG's Q1 results are likely to reflect higher earned premiums and strong core fixed income investment returns, offset by higher catastrophe losses.
ImageSource Recognized as an Aspirant in Everest Group's 2025 Intelligent Document Processing (IDP) PEAK Matrix® Assessment
09:02am, Thursday, 24'th Apr 2025
OLYMPIA, Wash.--(BUSINESS WIRE)--ImageSource, Inc., the enterprise automation company behind the ILINX® platform, announced today its recognition as an Aspirant in the 2025 Everest Group Intelligent
Earnings Preview: Everest Group (EG) Q1 Earnings Expected to Decline
11:07am, Wednesday, 23'rd Apr 2025
Everest Group (EG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EG Lags Industry, Trades at a Discount: What Should Investors Do Now?
10:55am, Thursday, 10'th Apr 2025
Everest Group remains poised to gain from strong renewal retention, continued favorable rate increases and prudent capital deployment.
Everest Announces Board Leadership Transition
04:50pm, Monday, 24'th Mar 2025
HAMILTON, Bermuda--(BUSINESS WIRE)--Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing best-in-class property, casualty, and specialty reinsurance and insurance solutions, announce
Everest Group to Hold First Quarter 2025 Earnings Conference Call on Thursday, May 1, 2025
04:15pm, Thursday, 20'th Mar 2025
HAMILTON, Bermuda--(BUSINESS WIRE)--Everest Group, Ltd. (“Everest”) (NYSE: EG) will hold its first quarter 2025 earnings conference call on Thursday, May 1, 2025, beginning at 8:00 am Eastern Time
TP named a Leader in Everest Group's 2024 Experience-Driven Integrated BFS Operations PEAK Matrix® Assessment
12:46pm, Thursday, 20'th Mar 2025
Company recognized for its deep expertise, industry experience and continuous innovation using AI technologies to drive client impact through integrated services solutions NEW YORK , March 20, 2025 /P
Everest Group Recognizes Chetu as a Leading Provider in Data and AI Services for Mid-Market Enterprises PEAK Matrix® Assessment 2025
12:32pm, Tuesday, 11'th Mar 2025
SUNRISE, Fla.--(BUSINESS WIRE)-- #AI--Everest Group has recognized Chetu in its 2025 “Data and AI Services for Mid-Market Enterprises PEAK Matrix® Assessment.”.
Everest Appoints John Howard to Board of Directors
04:15pm, Thursday, 06'th Mar 2025
HAMILTON, Bermuda--(BUSINESS WIRE)--Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing best-in-class property, casualty, and specialty reinsurance and insurance solutions, announce
Everest Medicines Announces First Patient Dosed with EVM16, Its First Internally Developed Personalized mRNA Cancer Vaccine
03:30am, Thursday, 06'th Mar 2025
The first patient has been dosed with EVM16 at Peking University Cancer Hospital, marking a major milestone as Everest's proprietary AI-based tumor neoantigen prediction algorithm and clinically valid
